Bayer Aktiengesellschaft BAYRY
Set alert
13.99 USD +0.62 +4.64%
At close · Oct 30
13.80 Day range 14.07
7.48 52-week range 15.23
- YTD
- +29.30%
- 1 year
- +81.69%
- Open
- 13.89
- Prev close
- 13.37
- Mkt cap
- 54.98B
- Vol
- 206.59K
- Avg vol
- 605.31K
- EPS
- -0.51
- P/E
- 0.00
More statistics
- Low
- 13.80
- High
- 14.07
- Earnings
- Nov 3, 2026
5D chart
Signals (54)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:50 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:30 AM | 2 days ago |
| RSI: Overbought | Oct 29, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:20 PM | 2 days ago |
| RSI: Overbought | Oct 29, 3:15 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:30 PM | 3 days ago |
| RSI: Overbought | Oct 29, 11:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:20 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:00 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:55 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:45 PM | 4 days ago |
| RSI: Overbought | Oct 27, 12:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:10 PM | 5 days ago |
| RSI: Overbought | Oct 27, 11:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:45 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:55 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:55 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:05 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:30 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:55 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:20 AM | 6 days ago |
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 0.13.
Financials — quick view
BAYRY Revenue — annual 28.96B
BAYRY Net income — annual 1.68B
BAYRY EPS — annual 2.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.13 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.23 | 0.29 | +0.06 | +26.09% |
| May 12, 2026 | Mar 31, 2026 | 0.64 | 0.79 | +0.15 | +23.44% |
| Mar 4, 2026 | Dec 31, 2025 | 0.18 | 0.18 | 0.00 | 0.00% |
| Nov 12, 2025 | Sep 30, 2025 | 0.13 | 0.17 | +0.04 | +30.77% |
| Aug 6, 2025 | Jun 30, 2025 | 0.25 | 0.35 | +0.10 | +40.00% |
News
- Bayer Gets in China Its First Global Approval for Stroke Prevention Drug
- Bayer: Turnaround Is Gaining Momentum, But Debt Remains A Risk
- Bayer to Present New Cardiac Amyloidosis and Heart Failure Data at the Heart Failure Society of America (HFSA) Annual Scientific Meeting
- Bayer Seeks Kerendia Label Expansion in Non-Diabetic CKD
- Actress and Menopause Advocate Melissa Joan Hart Partners with Bayer to Raise Awareness about Lynkuet® (elinzanetant), a Prescription Treatment for Moderate to Severe Hot Flashes due to Menopause
- U.S. FDA Accepts Bayer's Supplemental New Drug Application for KERENDIA® (finerenone) to Treat Adults with Chronic Kidney Disease (CKD) Without Diabetes
- BAYRY vs. RHHBY: Which Stock Should Value Investors Buy Now?
- Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
- Bayer to invest $2.2 billion in new US pharma site
- Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States
Your note
Sign in to keep a note on BAYRY — it syncs with the Stock Master app.